Evidence map›Paper›PMID 19959873›Full record

ArticleThe Journal of clinical investigation2009

Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Béatrice Jacquelin, Véronique Mayau, Brice Targat, Anne-Sophie Liovat, Désirée Kunkel, Gaël Petitjean, Marie-Agnès Dillies, Pierre Roques, Cécile Butor, Guido Silvestri and 5 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 308 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
308citing papers in PubMed, 4 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

308 citing papers in PubMed, 4 syntheses or guidelines pooled it, 476 citations in OpenAlex.

  1. The Hitchhiker Guide to CD4Frontiers in immunology · 2021
    Pooled it
  2. Transcriptional insights into the CD8Journal of translational medicine · 2020
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Tenofovir, Interferon Pathways, and Mucosal Immunity: Implications for People Living With HIV.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

248 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Béatrice JacquelinInstitut Pasteur, Unité de Régulation des Infections Rétrovirales, Paris, France.
Véronique Mayau
Brice Targat
Anne-Sophie Liovat
Désirée Kunkel
Gaël Petitjean
Marie-Agnès Dillies
Pierre Roques
Cécile Butor
Guido Silvestri
Luis D Giavedoni
Pierre Lebon
Françoise Barré-Sinoussi
Arndt Benecke
Michaela C Müller-Trutwin
Institut Pasteur · FRInstitut des Hautes Études Scientifiques · FRHôpital Saint-Vincent-de-Paul · FRInfectious Disease Models and Innovative Therapies · FRTexas Biomedical Research Institute · USUniversité Paris Cité · FR

Funding

WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GAUDUIN, MARIE-CLAIRE ELISABETH · 1999 to 2011
$79.1M
NCRR NIH HHS P51 RR013986
6 · The paper itself

Abstract

African green monkeys (AGMs) infected with the AGM type of SIV (SIVagm) do not develop chronic immune activation and AIDS, despite viral loads similar to those detected in humans infected with HIV-1 and rhesus macaques (RMs) infected with the RM type of SIV (SIVmac). Because chronic immune activation drives progressive CD4+ T cell depletion and immune cell dysfunctions, factors that characterize disease progression, we sought to understand the molecular basis of this AGM phenotype. To this end, we longitudinally assessed the gene expression profiles of blood- and lymph node-derived CD4+ cells from AGMs and RMs in response to SIVagm and SIVmac infection, respectively, using a genomic microarray platform. The molecular signature of acute infection was characterized, in both species, by strong upregulation of type I IFN-stimulated genes (ISGs). ISG expression returned to basal levels after postinfection day 28 in AGMs but was sustained in RMs, especially in the lymph node-derived cells. We also found that SIVagm induced IFN-alpha production by AGM cells in vitro and that low IFN-alpha levels were sufficient to induce strong ISG responses. In conclusion, SIV infection triggered a rapid and strong IFN-alpha response in vivo in both AGMs and RMs, with this response being efficiently controlled only in AGMs, possibly as a result of active regulatory mechanisms.

Indexed as

AnimalsCD4-Positive T-LymphocytesChlorocebus aethiopsGene Expression ProfilingHIV-1HIV InfectionsHost-Pathogen InteractionsHumansInterferon-alphaInterferon Type IMacaca mulattaOligonucleotide Array Sequence AnalysisSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusSpecies SpecificityVirulenceInterferon-alphaInterferon Type I

Identifiers

PMID19959873
PMCPMC2786805
OpenAlexW2104586170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.